News | January 21, 2007

Washington Hospital to Offer Leksell Gamma Knife

January 22, 2007 - Washington Hospital will be among the first facilities in the world to offer the Leksell Gamma Knife Perfexion by Elekta, a stereotactic radiosurgery treatment device for surgery on brain tumors.
Located in Washington Hospital's new Taylor McAdam Bell Neuroscience Institute, Gamma Knife Perfexion will be used for brain tumor therapy, spine surgery and neurodegenerative disorders, and controversies in cerebrovascular disease. Gamma Knife
radiosurgery is minimally invasive, so the risks of surgical complications are lessened and these procedures are performed on an outpatient basis.
"The Perfexion will be the cornerstone of the new Taylor McAdam Bell Neuroscience Institute and provides a potentially life-saving technology to patients in the surrounding communities, as well as referral patients from throughout the United States," said Nancy Farber, chief executive officer of Washington Hospital Healthcare System. "The Gamma Knife program will have experienced and skilled staff led by internationally known co-medical directors Sandeep Kunwar, M.D., and David Larson, M.D., Ph.D."

Related Content

more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Surgery and High-Dose SBRT Radiation Can Be Combined to Treat Kidney Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | July 05, 2017
A new study from Roswell Park Cancer Institute reporting the findings of the first clinical trial to evaluate the...
ASTRO Issues Guideline for Stereotactic Radiation Use in Early-Stage Lung Cancer
Feature | Lung Cancer | June 23, 2017
The American Society for Radiation Oncology (ASTRO) recently issued a new clinical guideline for the use of...
stereotactic body radiation therapy (SBRT)
News | Stereotactic Body Radiation Therapy (SBRT) | June 12, 2017
The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline for the use of stereotactic body...
Stereotactic Radiation Highly Effective for Kidney Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | May 03, 2017
Kidney cancer patients may soon have an alternative to traditional treatments, according to new research at UT...
SBRT, stereotactic body radiation therapy, early-stage lung cancer, patients 80 and older, 2017 Multidisciplinary Thoracic Cancers Symposium, study
News | Stereotactic Body Radiation Therapy (SBRT) | March 20, 2017
Patients in their 80s and 90s who have early-stage lung cancer but cannot undergo an operation can be treated safely...
prostate cancer, partial gland, SBRT, clinical trial, UH Hospitals
News | Stereotactic Body Radiation Therapy (SBRT) | April 28, 2016
Physicians at University Hospitals Seidman Cancer Center (Cleveland) have started a clinical trial using a new form of...
prostate cancer, stereotactic body radiation therapy, SBRT, cure rate, UT Southwestern Study
News | Prostate Cancer | April 19, 2016
A five-year study shows that stereotactic body radiation therapy (SBRT) offers a higher cure rate for prostate cancer...
Overlay Init